Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Common Shares
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Total
Balance at Dec. 31, 2018 $ 0 $ 179,503,000 $ (45,000) $ (175,640,000)   $ 3,818,000
Balance (in shares) at Dec. 31, 2018 769,896          
Release of vested restricted common stock $ 0 (87,000)       (87,000)
Release of vested restricted common stock (in shares) 26,706          
Issuance of warrants for common stock $ 0 46,000 0 0   46,000
Issuance of convertible preferred stock and common stock warrant, net of issuance costs 0 200,000 0 0 $ 720,000 200,000
Issuance of convertible preferred stock and common stock warrant, net of issuance costs (in shares)         250,000  
Fair value of derivative liability in connection with issuance of convertible preferred stock 0   0 0 $ (216,000) 0
Issuance of warrants for common stock in connection with convertible preferred stock offering 0 43,000 0 0 (43,000) 43,000
Issuance of common stock, net of issuance costs $ 0 6,149,000       6,149,000
Issuance of common stock, net of issuance costs (in shares) 328,786          
Convertible/Accretion preferred stock dividend $ 0 56,000 0 0 (56,000) 56,000
Foreign currency translation adjustment 0 0 (3,000) 0 0 (3,000)
Issuance of common stock for services $ 0 246,000 0 0 0 246,000
Issuance of common stock for services (in shares) 8,639          
Proceeds from issuance of pre-funded warrants and exercise of common stock warrants $ 0 1,167,000 0 0 0 1,167,000
Proceeds from issuance of pre-funded warrants and exercise of common stock warrants (in shares) 56,419          
Issuance of common stock for warrant settlement $ 0 112,000 0 0   112,000
Issuance of common stock for warrant settlement (in shares) 7,647          
Stock-based compensation $ 0 105,000       105,000
Stock-based compensation (in shares) 47,145          
Change in fair value of common stock warrants upon repricing $ 0 892,000       892,000
Net loss 0 0 0 (12,038,000) 0 (12,038,000)
Balance at Dec. 31, 2019 $ 0 188,320,000 (48,000) (187,678,000) $ 517,000 594,000
Balance (in shares) at Dec. 31, 2019 1,245,238       250,000  
Issuance of common stock, net of issuance costs $ 1,000 16,155,000       16,156,000
Issuance of common stock, net of issuance costs (in shares) 5,931,062          
Issuance of common stock in connection with notes payable $ 0 4,000       4,000
Issuance of common stock in connection with notes payable (in shares) 500          
Issuance of warrants in connection with convertible notes payable $ 0 630,000       630,000
Deemed dividend from warrant down-round provision 0 (134,000)       (134,000)
Warrant repricing 0 134,000       134,000
Convertible/Accretion preferred stock dividend 0 (80,000)     $ 80,000 (80,000)
Restricted stock awards cancelled $ 0          
Restricted stock awards cancelled (in shares) (4,550)          
Proceeds from the exercise of prefunded warrants and common stock warrants $ 0 789,000       789,000
Proceeds from the exercise of prefunded warrants and common stock warrants (in shares) 805,000          
Stock-based compensation $ 0 958,000 0 0 0 958,000
Stock-based compensation (in shares) 128,375          
Change in foreign currency translation from closure of subsidiary $ 0   48,000     48,000
Net loss 0 0 $ 0 (12,705,000) 0 (12,705,000)
Balance at Dec. 31, 2020 $ 1,000 207,698,000   $ (200,383,000) $ 597,000 7,316,000
Balance (in shares) at Dec. 31, 2020 8,402,250       250,000  
Issuance of common stock and warrants in connection with settlements $ 0 $ 922,000       $ 922,000
Issuance of common stock and warrants in connection with settlements (in shares) 296,625